In this question-and-answer discussion of "generic" biologics, the authors contend small changes in manufacturing of biologics dramatically affect the safety and efficacy of the therapeutic molecule.
Thomas Copmann
Advertisement
Articles by Thomas Copmann
Advertisement
Latest Updated Articles
Biologics: Can There Be Abbreviated Applications, Generics, or Follow-On Products?Published: July 1st 2003 | Updated:
Advertisement
Advertisement
